At around 1.25 PM. Aurobindo stock was trading at Rs890.85 per piece up 1.05% on Sensex.
In a notification on the website, the company said on August 12, Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Methocarbamol Tablets USP, 750 mg.
Methocarbamol in USP, 750 mg is an AB-rated generic equivalent to the reference listed drug (RLD), Robaxin-750 tablets of Auxilium Pharmaceuticals, LLC.
The tablet indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.